These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11091155)

  • 21. Multistep carcinogenesis and genital papillomavirus infection. Implications for diagnosis and vaccines.
    Rangel LM; Ramírez M; Torroella M; Pedroza A; Ibarra V; Gariglio P
    Arch Med Res; 1994; 25(2):265-72. PubMed ID: 7919824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV vaccine.
    AIDS Patient Care STDS; 1999 Feb; 13(2):76. PubMed ID: 11362122
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of mature dendritic cells for anti-human papillomavirus peptide-based vaccination in transplant patients.
    Mariat C; Alamartine E; Sabido O; Berthoux F
    Transplant Proc; 2002 Nov; 34(7):2836-7. PubMed ID: 12431627
    [No Abstract]   [Full Text] [Related]  

  • 24. HPV vaccination: more questions than answers.
    Noller KL
    Obstet Gynecol; 2006 Jan; 107(1):4-5. PubMed ID: 16394032
    [No Abstract]   [Full Text] [Related]  

  • 25. CDC recommends expensive vaccine for all girls aged 11-12.
    Tanne J
    BMJ; 2006 Jul; 333(7559):114. PubMed ID: 16840454
    [No Abstract]   [Full Text] [Related]  

  • 26. Preventing cervical cancer by vaccinating against HPV.
    Campbell K
    Nurs Times; 2005 Nov 15-21; 101(46):21-2. PubMed ID: 16315796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential of human papillomavirus vaccines.
    Steinbrook R
    N Engl J Med; 2006 Mar; 354(11):1109-12. PubMed ID: 16540608
    [No Abstract]   [Full Text] [Related]  

  • 28. How will HPV vaccines affect cervical cancer?
    Roden R; Wu TC
    Nat Rev Cancer; 2006 Oct; 6(10):753-63. PubMed ID: 16990853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global aspirations for HPV vaccination.
    Senior K
    Lancet Infect Dis; 2008 Mar; 8(3):150. PubMed ID: 18363221
    [No Abstract]   [Full Text] [Related]  

  • 30. Routine vaccination against human papillomavirus.
    Lancet Infect Dis; 2008 Mar; 8(3):141. PubMed ID: 18291330
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of papillomavirus and immunodeficiency virus evolutionary patterns in the context of a papillomavirus vaccine.
    Halpern AL
    J Clin Virol; 2000 Oct; 19(1-2):43-56. PubMed ID: 11091147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are we closer to the prevention of HPV-related diseases?
    Harper DM
    J Fam Pract; 2005 Jul; Suppl HPV Prevention():S10-6; quiz S23. PubMed ID: 16093008
    [No Abstract]   [Full Text] [Related]  

  • 33. Overcoming barriers to HPV vaccine acceptance.
    Mayneux EJ
    J Fam Pract; 2005 Jul; Suppl HPV Prevention():S17-22; quiz S23. PubMed ID: 16093009
    [No Abstract]   [Full Text] [Related]  

  • 34. Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer.
    Brown DR; Bryan JT; Schroeder JM; Robinson TS; Fife KH; Wheeler CM; Barr E; Smith PR; Chiacchierini L; DiCello A; Jansen KU
    J Infect Dis; 2001 Nov; 184(9):1183-6. PubMed ID: 11598842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes.
    Roden RB; Yutzy WH; Fallon R; Inglis S; Lowy DR; Schiller JT
    Virology; 2000 May; 270(2):254-7. PubMed ID: 10792983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Can human papillomavirus testing and vaccination prevent cervical cancer?].
    Lie AK; Bjørge T; Helland A; Hagen B; Skjeldestad FE; Hagmar B; Thoresen S
    Tidsskr Nor Laegeforen; 2001 Oct; 121(25):2947-51. PubMed ID: 11715778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 18th International Papillomavirus Conference.
    Bonnez W
    Antivir Ther; 2000 Dec; 5(4):279-83. PubMed ID: 11142623
    [No Abstract]   [Full Text] [Related]  

  • 38. [Perspectives for the development of vaccines and immunotherapy against cervico-uterine cancer].
    Guzmán-Rojas L; Alcocer-González JM; Madrid-Marina V
    Salud Publica Mex; 1998; 40(1):38-46. PubMed ID: 9567657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDA approves Gardasil 9 for more types of HPV.
    Printz C
    Cancer; 2015 Apr; 121(8):1156-7. PubMed ID: 25855331
    [No Abstract]   [Full Text] [Related]  

  • 40. Eligibility and willingness of young Icelandic women to participate in a HPV vaccination trial.
    Gudmundsdóttir T; Tryggvadóttir L; Allende M; Mast TC; Briem H; Sigurdsson K
    Acta Obstet Gynecol Scand; 2003 Apr; 82(4):345-50. PubMed ID: 12716319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.